Related Experiment Video
Updated: May 11, 2026
08:54
Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Optimizing antifungal choice and administration.
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. dra@medicine.wisc.edu
Current Medical Research and Opinion
|April 30, 2013
Summary
Optimizing antifungal selection for invasive fungal infections (IFIs) requires matching drug properties like spectrum and pharmacokinetics to patient needs and pathogen. Careful consideration of drug interactions and toxicity ensures effective treatment.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- The management of invasive fungal infections (IFIs) involves a diverse range of antifungal drugs.
- Effective IFI treatment hinges on selecting the right drug for the patient and pathogen, optimizing dosage, and managing toxicity.
Purpose of the Study:
- To provide a concise overview of critical factors in optimizing antifungal selection and administration for IFIs.
- To guide clinicians in making informed therapeutic decisions for patients with IFIs.
Main Methods:
- Review of antifungal drug characteristics, including spectrum of activity, pharmacokinetics, and toxicity.
- Analysis of factors influencing drug choice, such as patient's immune status, pathogen epidemiology, and infection site.
- Consideration of drug interactions and therapeutic drug monitoring.
Main Results:
- Antifungal agents vary significantly in their spectrum of activity, necessitating pathogen-specific or epidemiologically informed choices.
- Pharmacokinetic variability (e.g., triazoles) and drug-drug interactions (e.g., cytochrome P450) require careful management.
- Drug distribution to specific sites (e.g., CNS) and toxicity profiles are crucial determinants in antifungal selection.
Conclusions:
- Successful IFI management depends on accurately selecting antifungal agents based on drug characteristics and patient-specific factors.
- Matching the antifungal's spectrum, pharmacokinetics, pharmacodynamics, toxicity, and distribution to the infection site is key.
- Individualized drug selection, considering patient and pathogen, optimizes IFI treatment outcomes.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:19Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...